back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-03 13:09 Tx date 2025-06-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$56,349
+11,715 vol $4.81 each |
206,523 | |
| Filed 2025-04-01 12:02 Tx date 2025-03-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$93,406
+20,529 vol $4.55 each |
194,808 | |
| Filed 2025-01-08 15:12 Tx date 2024-12-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$165,783
+42,184 vol $3.93 each |
141,284 | |
| Filed 2025-01-03 15:23 Tx date 2024-12-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$52,048
+13,806 vol $3.77 each |
174,279 | |
| Filed 2024-12-16 12:45 Tx date 2024-12-12 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,825
+2,100 vol $3.25 each |
99,100 | |
| Filed 2024-10-03 09:46 Tx date 2024-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$48,961
+13,451 vol $3.64 each |
160,473 | |
| Filed 2024-07-05 10:17 Tx date 2024-06-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$49,615
+14,550 vol $3.41 each |
147,022 | |
| Filed 2024-04-01 14:03 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$49,118
+12,926 vol $3.80 each |
132,472 | |
| Filed 2024-03-25 13:40 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$217,362
+53,275 vol $4.08 each |
119,546 | |
| Filed 2024-01-04 16:09 Tx date 2023-12-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$31,847
+8,359 vol $3.81 each |
66,271 | |
| Filed 2023-10-05 15:06 Tx date 2023-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$31,887
+6,228 vol $5.12 each |
57,912 | |
| Filed 2023-07-05 15:38 Tx date 2023-06-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$34,983
+6,063 vol $5.77 each |
51,684 | |
| Filed 2023-06-12 15:51 Tx date 2023-06-08 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$417,100
+97,000 vol $4.30 each |
97,000 | |
| Filed 2023-06-12 15:49 Tx date 2021-06-18 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-04 16:29 Tx date 2023-03-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$20,363
+3,322 vol $6.13 each |
45,621 | |
| Filed 2023-01-04 15:29 Tx date 2022-12-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$19,578
+2,048 vol $9.56 each |
42,299 | |
| Filed 2022-12-16 16:01 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$204,040
+20,182 vol $10.11 each |
40,251 | |
| Filed 2022-10-05 16:06 Tx date 2022-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$19,143
+2,151 vol $8.90 each |
20,069 | |
| Filed 2022-07-05 15:10 Tx date 2022-06-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,987
+1,519 vol $12.50 each |
17,918 | |
| Filed 2022-01-11 15:44 Tx date 2021-12-31 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,905
+1,252 vol $15.10 each |
15,136 | |
| Filed 2022-01-11 15:43 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,416
+1,013 vol $18.18 each |
1,013 | |
| Filed 2021-12-13 17:03 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,489
+962 vol $18.18 each |
||
| Filed 2021-12-13 17:04 Tx date 2021-12-08 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$191,520
+12,871 vol $14.88 each |
13,833 | |
| Filed 2021-12-13 17:03 Tx date 2021-09-30 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$17,489
+962 vol $18.18 each |
962 | |
| Filed 2021-12-13 17:02 Tx date 2021-06-18 |
$HLS
HLS Therapeutics Inc. |
Welborn, Jr., John Lee
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|